ArticleBMC urology2025
"Double rings" En-bloc technique with early anatomical apical release in thuflep for the patients with large glands (≥ 80 mL): the outcomes from single center.
Article in BMC urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Efficacy of transurethral thulium laser vapoenucleation of the prostate combined with 12-o'clock urethral mucosal preservation for small-volume benign prostatic hyperplasia: a retrospective study.World journal of urology · 2026Article
- Thulium fiber laser enucleation of the prostate (ThuFLEP) for the treatment of benign prostatic obstruction: a comparative study of men with prostate volumes ≥ 150 mL and < 150 mL.World journal of urology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
background and purposeWe aimed to describe the technique and outcomes of "Double Rings" En-bloc thulium fiber laser enucleation of the prostate (ThuFLEP) with early anatomical apical release in benign prostatic hyperplasia (BPH) with large glands (≥ 80 mL). PATIENTS AND
methodsA total of 68 BPH patients with large glands (≥ 80 mL) who received our technique performed by a single surgeon were enrolled between January 2021 and January 2022. The parameter set of thulium fiber laser was 1.5 J/40 Hz (60 W). Enucleation was performed using the "Double Rings" technique. The first ring was created by circumferentially incising the urethral mucosa around the adenoma at the apex. The second ring was formed by dissecting the bladder neck at 12 o'clock position, which served as a landmark for guiding further dissection. The adenoma was then pushed into the bladder, and the bleeding points of the prostatic fossa were coagulated with a thulium fiber laser to ensure hemostasis. We analyzed patient demographic, perioperative and two-year follow-up data.
resultsMean preoperative prostate volume was 135 ml (range, 80-275). Mean preoperative International Prostate Symptom Score (IPSS) was 21.1 (range, 17.8-29.6). Mean preoperative quality of life (QoL) score was 4.7 (range, 3-5). Mean operative time was 88.6 min (range, 40-199). Mean enucleated tissue weight was 70.8 g (range, 30-162). The rate of postoperative complication was 11.8% (2 fevers and 6 urinary tract infections), which were manageable. No blood transfusion. IPSS, QoL score, peak urinary flow rate, and postvoid residual urine volume were all significantly improved (p < 0.01). Six patients had transient early stress urinary incontinence (SUI), but all recovered in 3 months. Over a follow-up of 38.2 months (range: 28-45 months), no urethral stricture or bladder neck contracture were detected. No patient developed permanent SUI.
conclusions"Double Rings" En-bloc technique with early anatomical apical release in ThuFLEP seems to be a safe and effective approach for BPH patients with large glands. However, multi-center and large sample studies are still needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.